Direct Medical Costs of Multiple Sclerosis and Regional Diversity in Access to Disease-Modifying Therapies in Poland Between 2008-2016
Abstract
Authors
K Orlewska A Sliwczynski M Brzozowska W Wierzba M Marczak E Orlewska
K Orlewska A Sliwczynski M Brzozowska W Wierzba M Marczak E Orlewska
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now